SCHEMBL26685643

SCHEMBL26685643

Brc1cc2[nH]nc(Br)c2cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 3/20 0.37
PDPK1 O15530 2/20 0.37
DYRK1A Q13627 4/20 0.35
IDO1 P14902 2/20 0.32
TDO2 P48775 1/20 0.32
MAP4K4 O95819 2/20 0.32
CSF1R P07333 2/20 0.32
CLK2 P49760 2/20 0.32
MAP4K2 Q12851 2/20 0.32
AURKB Q96GD4 2/20 0.32
CLK4 Q9HAZ1 2/20 0.32
CHEK1 O14757 1/20 0.32
AURKA O14965 1/20 0.32
DAPK3 O43293 1/20 0.32
PAK4 O96013 1/20 0.32
ABL1 P00519 1/20 0.32
RET P07949 1/20 0.32
IGF1R P08069 1/20 0.32
FGFR1 P11362 1/20 0.32
PDGFRA P16234 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31543243 1.00 JAK2 (0.37) JAK2PDPK1DYRK1AIDO1TDO2
SCHEMBL21055463 0.80 GABRP (0.36) JAK2PDPK1DYRK1AIDO1TDO2
SCHEMBL30056844 0.80 GABRP (0.36) JAK2PDPK1DYRK1AIDO1TDO2
SCHEMBL16340015 0.80 PDPK1 (0.35) JAK2PDPK1DYRK1AIDO1TDO2
SCHEMBL30661625 0.80 PDPK1 (0.35) JAK2PDPK1DYRK1AIDO1TDO2
SCHEMBL24159871 0.76 TTK (0.33) JAK2PDPK1DYRK1ACHEK1
SCHEMBL29563762 0.76 TTK (0.33) JAK2PDPK1DYRK1ACHEK1
SCHEMBL24087052 0.76 CHEK1 (0.45) JAK2PDPK1CHEK1
SCHEMBL22580854 0.73 MAPT (0.33) JAK2DYRK1AMAP4K4CLK2MAP4K2
SCHEMBL31543364 0.70 PIM1 (0.43) JAK2PDPK1DYRK1AABL1PRKAA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522612-A1 TYK2 INHIBITORS Biogen MA Inc. (US) 2025-03-19 EP disclosed
WO-2023220046-A1 TYK2 INHIBITORS BIOGEN MA INC. (US) 2023-11-16 WO disclosed